Bévacizumab et Cancer colorectal

(5:9)

Dr. Balar Discusses Bevacizumab in Bladder Cancer

(1:17)

Assessing the Use of Bevacizumab

(4:12)

Ovarian Cancer Subtypes May Predict Response to Bevacizumab

(1:59)

Breast cancer drug Avastin

(29)

FDA Revokes Avastin for Breast Cancer Use

(53)

Real-world use of bevacizumab in patients with breast cancer

(1:19)

Immunotherapy Combined With Mirvetuximab and Avastin

(2:25)

FDA Changes Position on Cancer Drug Avastin

(1:45)

How Targeted Therapy Avastin (Bevacizumab) Treats Metastatic Cancer

(2:24)

Treatment with Avastin May be Cut Short

(44)

Why has everything beyond bevacizumab failed in angiogenesis inhibition?

(18:4)

PAOLA-1 Phase 3 data: olaparib plus bevacizumab maintenance for advanced ovarian cancer

(9:49)

Dr. Tew Evaluates Bevacizumab Treatment in Ovarian Cancer

(1:36)

Bevacizumab in Ovarian Cancer

(8:15)

Dr. Burger on the Use of Bevacizumab in Ovarian Cancer

(1:8)

Tanios Bekaii-Saab, MD: Bevacizumab Side-Effects

(2:21)

Bevacizumab and cetuximab (plus chemotherapy) equally effective for colorectal cancer patients

(11:15)

Michel Ducreux, ESMO 2018 – Exploring new treatment options for hepatocellular carcinoma

(3:2)